American Shared Hospital Services Announces Start of Patient Treatments at its Radiation Therapy Facility, A.B. Radiocirugía y Radioterapia de Puebla, in Puebla, Mexico
American Shared Hospital Services (NYSE American: AMS) has begun patient treatments at its new radiation therapy facility, A.B. Radiocirugía y Radioterapia de Puebla, in Puebla, Mexico. This facility is a joint venture with Guadalupe Amor Y Bien, with AMS holding an 85% ownership stake. The facility features an Elekta Versa HD linear accelerator, upgrading from Guadalupe's previous older equipment.
The new facility serves a population of over six million and offers advanced treatment techniques including IMRT, VMAT, SBRT, and Radiosurgery. This expansion is part of AMS's international strategy, which includes existing Gamma Knife centers in Peru and Ecuador, and a recently announced joint venture in Guadalajara, Mexico.
American Shared Hospital Services (NYSE American: AMS) ha iniziato i trattamenti per i pazienti nella sua nuova struttura di terapia radiativa, A.B. Radiocirugía y Radioterapia de Puebla, a Puebla, Messico. Questa struttura è una joint venture con Guadalupe Amor Y Bien, con AMS che detiene una partecipazione di proprietà dell'85%. La struttura è dotata di un acceleratore lineare Elekta Versa HD, con un aggiornamento rispetto alle precedenti attrezzature più obsolete di Guadalupe.
La nuova struttura serve una popolazione di oltre sei milioni e offre tecniche di trattamento avanzate tra cui IMRT, VMAT, SBRT e Radiosurgery. Questa espansione fa parte della strategia internazionale di AMS, che include centri Gamma Knife esistenti in Perù ed Ecuador, e una recente joint venture annunciata a Guadalajara, Messico.
American Shared Hospital Services (NYSE American: AMS) ha comenzado tratamientos para pacientes en su nueva instalación de terapia radiante, A.B. Radiocirugía y Radioterapia de Puebla, en Puebla, México. Esta instalación es una joint venture con Guadalupe Amor Y Bien, donde AMS posee una participación del 85%. La instalación cuenta con un acelerador lineal Elekta Versa HD, mejorando el equipo anterior de Guadalupe.
La nueva instalación atiende a una población de más de seis millones y ofrece técnicas de tratamiento avanzadas que incluyen IMRT, VMAT, SBRT y Radiosurgery. Esta expansión es parte de la estrategia internacional de AMS, que incluye centros Gamma Knife existentes en Perú y Ecuador, y una joint venture recientemente anunciada en Guadalajara, México.
아메리칸 쉐어드 병원 서비스(NYSE American: AMS)가 멕시코 푸에블라에 있는 새로운 방사선 치료 시설 A.B. 라디오수르기아 y 라디오테라피아 데 푸에블라에서 환자 치료를 시작했습니다. 이 시설은 AMS가 85%의 지분을 보유한 과달루페 아모르 이 비엔과의 합작 투자입니다. 이 시설은 과달루페가 사용하던 이전의 낡은 장비에서 업그레이드된 Elekta Versa HD 선형 가속기를 갖추고 있습니다.
새로운 시설은 600만 명 이상의 인구를 대상으로 하며 IMRT, VMAT, SBRT 및 방사선 수술을 포함한 고급 치료 기술을 제공합니다. 이 확장은 AMS의 국제 전략의 일환으로, 페루와 에콰도르에 기존의 감마 나이프 센터와 최근에 과달라하라, 멕시코에서 발표된 합작 투자도 포함됩니다.
American Shared Hospital Services (NYSE American: AMS) a commencé les traitements pour les patients dans sa nouvelle installation de thérapie par radiation, A.B. Radiocirugía y Radioterapia de Puebla, à Puebla, Mexique. Cette installation est une joint venture avec Guadalupe Amor Y Bien, avec AMS détenant une participation de 85%. L'installation dispose d'un accélérateur linéaire Elekta Versa HD, mis à jour par rapport à l'équipement plus ancien de Guadalupe.
La nouvelle installation dessert une population de plus de six millions et propose des techniques de traitement avancées incluant l'IMRT, le VMAT, le SBRT et la radiosurgie. Cette expansion fait partie de la stratégie internationale d'AMS, qui comprend des centres Gamma Knife existants au Pérou et en Équateur, ainsi qu'une joint venture récemment annoncée à Guadalajara, au Mexique.
American Shared Hospital Services (NYSE American: AMS) hat mit der Behandlung von Patienten in seiner neuen Strahlentherapieeinrichtung A.B. Radiocirugía y Radioterapia de Puebla in Puebla, Mexiko, begonnen. Diese Einrichtung ist ein Joint Venture mit Guadalupe Amor Y Bien, wobei AMS 85% der Anteile hält. Die Einrichtung verfügt über einen Elekta Versa HD Linearbeschleuniger, der das frühere, veraltete Equipment von Guadalupe ersetzt.
Die neue Einrichtung bedient eine Bevölkerung von über sechs Millionen und bietet fortschrittliche Behandlungstechniken wie IMRT, VMAT, SBRT und Radiosurgery an. Diese Expansion ist Teil der internationalen Strategie von AMS, die vorhandene Gamma Knife-Zentren in Peru und Ecuador sowie ein kürzlich bekannt gegebenes Joint Venture in Guadalajara, Mexiko, umfasst.
- Expansion into the Mexican market with a new radiation therapy facility
- 85% ownership stake in the joint venture
- Upgraded equipment (Elekta Versa HD linear accelerator) offering advanced treatment techniques
- Serving a large population of over six million people
- Introduction of the first radiosurgery device in the region
- Potential for increased demand due to improved treatment options and reduced travel for patients
- None.
The introduction of Elekta Versa HD linear accelerator in Puebla marks a significant technological upgrade for the region. This advanced linac offers multiple treatment techniques including IMRT, VMAT, SBRT and Radiosurgery, which are substantial improvements over older systems. The ability to perform radiosurgery locally is particularly noteworthy, as it can reduce treatment sessions and patient travel.
From a market perspective, being the first and only radiosurgery device in a region of over six million people presents a considerable competitive advantage. The potential for increased patient volume and expanded treatment options could drive significant revenue growth for AMS in this market. However, the success will depend on factors such as local healthcare infrastructure, insurance coverage and patient awareness of these advanced treatment options.
AMS's expansion into Mexico through this joint venture is a strategic move that aligns with their international growth plans. By holding an 85% ownership stake, AMS positions itself to capture a significant portion of the potential revenue stream. The partnership model, where AMS provides the technology and Guadalupe covers site modifications, demonstrates a capital-efficient approach to market entry.
The reopening of a previously established facility (closed since 2020) with upgraded technology could accelerate patient acquisition, leveraging existing local relationships. However, investors should monitor the ramp-up period closely, as reestablishing operations and building patient volume may take time. The success of this venture could serve as a blueprint for further expansion in Mexico and other emerging markets, potentially driving long-term growth for AMS.
SAN FRANCISCO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that it has begun treating patients at its Radiation Therapy Facility, A.B. Radiocirugía y Radioterapia de Puebla (“A.B.”), in Puebla, Mexico, located 80 miles from Mexico City.
AMS has a Joint Venture (“JV”) agreement with the principal owners of Guadalupe Amor Y Bien (“Guadalupe”) to treat public and private cancer patients at A.B. AMS and Guadalupe hold
Guadalupe Amor Y Bien was a well-established, privately owned radiation therapy facility. Founded in 1997, Guadalupe introduced the first linac in the region which has a population of over six million people. The facility had not previously operated since 2020. A.B. Radiocirugía y Radioterapia de Puebla is staffed by an administrative and medical team, including a full-time Director General and radiation oncologist Medical Director, physicists and radiation therapists.
“We are excited about this first expansion of our international strategy into Mexico, which also includes our existing Gamma Knife centers in Peru and Ecuador. Moreover, we recently announced our joint venture agreement with Hospital San Javier to treat patients with the most advanced Leksell Gamma Knife Model Esprit in Guadalajara, Mexico,” said Ray Stachowiak, Executive Chairman and Chief Executive Officer. “We believe the start of patient treatments in Puebla with the Versa linac is a testament to AMS’ broadened product line and is ripe with opportunity. The upgrade to the Versa’s multiple treatment techniques, which includes IMRT, VMAT, SBRT and Radiosurgery, are expected to generate significant demand from the populous region.”
Ernest R. Bates, VP of Sales and Business Development-International at AMS, added, “The ability to offer additional treatment modalities to the region is expected to be a significant competitive advantage. The introduction of IMRT is expected to improve patient outcomes. The upgrade brings to fruition the first and only radiosurgery device to the region, where until now patients have been travelling 80 miles to Mexico City to receive these treatments. Importantly, the Versa’s radiosurgery capabilities allow patients to be treated in one session versus multiple treatments for other options, which is expected to further drive demand.”
AMS’ JV partner, Ms. Guadalupe Guzman Moreno, commented, “We are excited to begin treating patients and providing these much-needed services to the region again. The enhanced equipment that the JV affords will ensure that our patients won’t have to travel long distances to receive advanced care.”
About American Shared Hospital Services (NYSE American: AMS)
American Shared Hospital Services (ASHS) is a leading provider of creative financial and turnkey solutions to cancer treatment centers, hospitals, and large cancer networks worldwide. The Company works closely with all major global Original Equipment Manufacturers (OEMs) that provide leading edge clinical treatment systems and software to treat cancer using Radiation Therapy and Radiosurgery. The Company is vendor agnostic and provides financial support for a wide range of products including MR Guided Radiation Therapy Linacs, Advanced Digital Linear Accelerators, Proton Beam Therapy Systems, Brachytherapy systems and suites, and through the Company’s subsidiary, GK Financing LLC., the Leksell Gamma Knife product and services. For more information, please visit www.ashs.com.
Safe Harbor Statement
This press release may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services including statements regarding the expected continued growth of the Company and the expansion of the Company’s Gamma Knife, proton therapy and MR/LINAC business, which involve risks and uncertainties including, but not limited to, the risks of economic and market conditions, the risks of variability of financial results between quarters, the risks of the Gamma Knife and proton therapy businesses, the risks of changes to CMS reimbursement rates or reimbursement methodology, the risks of the timing, financing, and operations of the Company’s Gamma Knife, proton therapy, and MR/LINAC businesses, the risk of expanding within or into new markets, the risk that the integration or continued operation of acquired businesses could adversely affect financial results and the risk that current and future acquisitions may negatively affect the Company’s financial position. Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2023, and the definitive Proxy Statement for the Annual Meeting of Shareholders that was held on June 25, 2024.
Contacts:
American Shared Hospital Services
Ranjit Pradhan VP Of Marketing
P: (415) 788-5300 Ext 4021
rpradhan@ashs.com
Investor Relations
PCG Advisory, Inc.
Kirin Smith, President
ksmith@pcgadvisory.com
FAQ
What new facility has American Shared Hospital Services (AMS) opened in Mexico?
What equipment is installed at the new AMS facility in Puebla?
What is the ownership structure of the new AMS facility in Puebla?
How many people does the new AMS facility in Puebla serve?
What other international operations does AMS have?
